News

inFlow Inventory's New Tracking Puts Small Biz Ahead

inFlow Inventory's New Tracking Puts Small Biz Ahead

Small businesses can finally breathe a sigh of relief. inFlow Inventory has just thrown a lifeline to small manufacturers and distributors with its new lot number and expiry date tracking features. These folks, who’ve been meticulously jotting down lot numbers on every possible scrap of paper or juggling Excel sheets, now have a real chance to play with the big dogs.

Game-Changing Traceability

This isn’t just more software noise in your inbox; this is about real, tangible change. We’re talking batch-level traceability that narrows down exactly which peanuts went into Grandma's famous peanut butter, without bleeding a small business's budget dry. A feature traditionally reserved for the high-rollers with deep ERP pockets is now within reach for the little guys.

"Traceability shouldn't be a luxury feature," says Louis Leung, co-founder and CEO of inFlow Inventory. He's right. Small businesses shouldn't need a fat checkbook to keep their operations pristine.

How It Works

Let’s cut through the noise of industry jargon: this is what you’re getting. Every batch—be it food, pharmaceuticals, or those medical widgets—is traceable from receipt all the way to your customer's hands. Inventory mishmashed by expiry dates? Not here. The system sorts your stock at the snap of your fingers by how close they are to expiry.

We've got first-expired-first-out logic baked in—it’s the kind of stuff that keeps your stocks from rotting on the shelf. No more guesswork; it’s automated.

  • Batch Movement Insight: Know when your batch landed, what was concocted out of it, and when it sailed out.
  • Expiry Alerts: inFlow gives timely warnings before that hard-earned stock turns worthless.
  • Barcode Savvy: With advanced GS1 barcode support, there's no stone unturned in production tracking.

Step Aside, ERP

Enterprise solutions warned us about their costs and complex setups. This isn’t a company throwing out random promises; two years in development, a year of real-world testing with the exact kind of businesses who need these features the most, inFlow rolled up its sleeves and got down to business. They’re delivering the goods anyhow—you reach for your chequebook only to find no extra costs on Mid-Size plans and above.

Who's Benefiting?

When you get winds of this, you smell change in the air. It's not just food and beverage makers getting a scent of victory. Pharma distributors, medical device companies, cosmetics—any industry grappling with traceability headaches—they're all eyeing this solution like hawks. With genuine obligations breathing down their necks and no ERP budget to speak of, these companies are finally getting tools that fit their realities.

Why’s it matter? Trackability is where the battle lies for these industries. When a recall looms or shelf life is close to a blip, wasting time or stock just isn’t an option. This is for those who couldn’t drop the cash on big ERP dreams but crave its capabilities.

Final Thoughts

inFlow Inventory's latest offering is a game changer. It isn’t about just running lean, it's about staying lean. This feature rollout complements their already strong base of over 20 million products, while also tightly integrating with the likes of QuickBooks and Shopify for seamless operations.

Small manufacturers or distributors now have a fighting chance to get their inventories running smooth, without mortgaging the farm. That’s a win in my book, and worth every penny not spent on sprawling ERP setups.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Perrigo's Reinvention Strategy: A Path to Sustainable Success

Updated Category News Views 152

Perrigo Restructures for Future Growth and Performance Perrigo Company plc (NYSE: PRGO), a recognized leader in the consumer self-care products industry, has embarked on an ambitious path of organizational realignment aimed at ensuring sustainable growth and enhanced operational performance. This strategic initiative is expected to bolster agility and innovation within...

Continue Reading
Eli Lilly Prepares for Weight-Loss Drug Launch Amid FDA Review

Updated Category News Views 225

Eli Lilly's Strategic Inventory Build-Up Eli Lilly and Company (NYSE: LLY) has made headlines recently by accumulating an impressive $1.5 billion worth of inventory for its experimental oral weight-loss pill, orforglipron. This move comes in light of the anticipated decision by the FDA, which could take place in the near future. The increase in inventory value represents...

Continue Reading
Roblox's CFO Transition: Leadership Change and Future Prospects

Updated Category News Views 352

Roblox Corporation Announces CFO Transition Roblox Corporation (NYSE:RBLX) has recently made headlines as its Chief Financial Officer, Michael Guthrie, prepares to leave his post to focus on personal pursuits. This change reflects a significant moment in the company's leadership dynamics, with the announcement stemming from a formal Separation and Transition Agreement....

Continue Reading
MaxCyte's 2024 Financial Results Highlight Growth and Innovation

Updated Category News Views 149

MaxCyte Reports Positive Financial Results for 2024 MaxCyte, Inc. (NASDAQ: MXCT; LSE: MXCT), a renowned company at the forefront of cell engineering, has shared exciting preliminary financial outcomes for its fourth quarter and the entire year of 2024. These results demonstrate steady growth in revenue and a stronger position in the rapidly evolving cell therapy industry....

Continue Reading
XORTX Therapeutics Invites Shareholders to Participate Actively

Updated Category News Views 113

XORTX Therapeutics Encourages Shareholder Participation CALGARY, Alberta – XORTX Therapeutics Inc. (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a leading clinical pharmaceutical company focused on developing innovative therapies for progressive kidney disease, is reaching out to its shareholders. They want to remind everyone about the important voting deadline for the...

Continue Reading